AXA S.A. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AXA S.A. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,292,407
+19.0%
484,200
+93.0%
0.00%
-33.3%
Q4 2021$1,086,000
-7.9%
250,900
+8.3%
0.00%0.0%
Q3 2021$1,179,000
-24.9%
231,600
-3.4%
0.00%
-40.0%
Q4 2020$1,570,000
+46.6%
239,650
+48.7%
0.01%
+25.0%
Q3 2020$1,071,000
-27.3%
161,126
-9.0%
0.00%
+33.3%
Q2 2020$1,474,000177,0520.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,450,000$8,320,5001.17%
BVF INC/IL 6,595,801$8,508,5830.23%
Bronte Capital Management Pty Ltd. 925,245$1,193,5660.12%
Formidable Asset Management, LLC 318,111$410,3630.09%
Congress Park Capital LLC 112,450$145,0610.08%
Forefront Analytics, LLC 49,421$63,7540.04%
Ground Swell Capital, LLC 10,966$14,1460.02%
Clearline Capital LP 196,583$253,5920.02%
CORNERCAP INVESTMENT COUNSEL INC 81,352$104,9440.02%
ACADIAN ASSET MANAGEMENT LLC 2,646,190$3,4120.01%
View complete list of CYTOMX THERAPEUTICS INC shareholders